Trial · NCT07892560
Effects of Different Footbath Immersion Depths on Sleep Quality Among Older Adults in Long-Term Care Facilities
NCT07892560, Not applicable, Completed, Cai-Syuan Jiang
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Different Footbath Immersion Depths on Sleep Quality Among Older Adults in Long-Term Care Facilities. Trials, record NCT07892560. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892560
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Different Footbath Immersion Depths on Sleep Quality Among Older Adults in Long-Term Care Facilities
- NCT number
- NCT07892560
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Cai-Syuan Jiang
- Conditions
- Sleep Quality
- Interventions
- Ankle-Level Warm-Water Footbath, Below-Knee Warm-Water Footbath
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Subjective Sleep Quality Measured by the Verran and Snyder-Halpern Sleep Scale | Over seven consecutive days, from baseline to completion of the interventions, sleep quality was assessed before 9:00 a.m. each morning: once after the baseline night and twice after each two-night condition (ankle-level footbath, routine care, below-kne | Subjective sleep quality was assessed using the 15-item Verran and Snyder-Halpern Sleep Scale (VSH). Each item is scored from 0 to 100, with a total score ranging from 0 to 1,500. Higher total scores indicate better subjective sleep quality. The VSH was completed before 9:00 a.m. each morning to assess sleep quality during the previous night. For each study condition, the scores from two consecutive mornings were averaged and compared across the three conditions. |
| Primary | Total Sleep Time (TST) Measured by Wrist Actigraphy | Over seven consecutive nights per participant, from baseline to completion of the interventions, total sleep time was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath). | Total sleep time (TST) was measured using wrist actigraphy and expressed in minutes. It represents the total time spent asleep during the nighttime sleep period. The device was worn on the nondominant wrist overnight. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. TST values from two consecutive nights under each condition were averaged for analysis. |
| Primary | Sleep Latency (SL) Measured by Wrist Actigraphy | Over seven consecutive nights per participant, from baseline to completion of the interventions, sleep latency was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath). | Sleep latency (SL) was measured using wrist actigraphy and expressed in minutes. It represents the time from bedtime to sleep onset. The device was worn overnight on the nondominant wrist. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. SL values from two consecutive nights under each condition were averaged for analysis. |
| Primary | Wake After Sleep Onset (WASO) Measured by Wrist Actigraphy | Over seven consecutive nights per participant, from baseline to completion of the interventions, wake after sleep onset was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath | Wake after sleep onset (WASO) was measured using wrist actigraphy and expressed in minutes. It represents the total time spent awake after initially falling asleep during the nighttime sleep period. The device was worn overnight on the nondominant wrist. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. WASO values from two consecutive nights under each condition were averaged for analysis. |
| Primary | Sleep Efficiency (SE) Measured by Wrist Actigraphy | Over seven consecutive nights per participant, from baseline to completion of the interventions, sleep efficiency was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath). | Sleep efficiency (SE) was measured using wrist actigraphy and expressed as a percentage. It was calculated as total sleep time divided by time in bed, multiplied by 100. Higher percentages indicate greater sleep efficiency. The device was worn overnight on the nondominant wrist. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. SE values from two consecutive nights under each condition were averaged for analysis. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892560
GET https://conductscience.org/api/trials/v1/NCT07892560/registered